Overview of the use of recombinant factor VIIa in children
John Puetz Department of Pediatrics, Division of Hematology/Oncology, Cardinal Glennon Children's Medical Center, Saint Louis University, St Louis, MO, USA Abstract: Recombinant factor VIIa (rFVIIa) was initially developed as a bypassing agent to control bleeding in people with hemophilia wh...
Saved in:
| Hovedforfatter: | |
|---|---|
| Format: | Bog |
| Udgivet: |
Dove Medical Press,
2014-10-01T00:00:00Z.
|
| Fag: | |
| Online adgang: | Connect to this object online. |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
Internet
Connect to this object online.3rd Floor Main Library
| Klassifikationsnummer: |
A1234.567 |
|---|---|
| Kopi 1 | Tilgængelig |